Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a common antibiotic boost eczema treatment?

NCT ID NCT07713186

Not yet recruiting Disease control Sponsor: Cairo University Source: ClinicalTrials.gov ↗

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This trial investigates whether adding the antibiotic azithromycin to standard topical creams (betamethasone or tacrolimus) improves eczema symptoms in children aged 3 to 12 with mild to moderate atopic dermatitis. Researchers will measure changes in the Eczema Area and Severity Index (EASI) score over 8 weeks. The goal is to see if the combination works better than creams alone.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
azithromycin added to betamethasone or tacrolimus ointments
What this could lead to
If adding azithromycin works, it could offer a simple, low-cost way to boost the effectiveness of standard eczema creams.
What could go wrong
This is a small, early-phase trial with only 40 children, so results may not apply broadly. Azithromycin can cause side effects like stomach upset or allergic reactions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atopic eczema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATOPIC DERMATITIS

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cairo University

    Cairo, Saray, 11562, Egypt

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.